Clinical Trial Update: A Study of PD5K3 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PD5K3 in healthy adult volunteers; the study has completed and investigated safety and pharmacokinetics. Conditions listed inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• PD5K3

Snippet

Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. | Conditions: Lymphoblastic Leukemia, Acute, Lymphoblastic Lymphoma | Phase 1 | Status: COMPLETED